Surmodics Inc reports results for the quarter ended in December - Earnings Summary

SurModics

01/02/2024 14:32

* Surmodics Inc  SRDX.OQ  reported quarterly breakeven
results​​
per share for the quarter ended in December, higher than the
same quarter last year, when the company reported EPS of -50
cents.  The mean expectation of four analysts for the quarter
was for a loss of 30 cents per share. Wall Street expected
results to range from -35 cents to -24 cents per share.
    * Revenue rose 22.5% to $30.55 million from a year ago;
analysts
expected $29.64 million. 
    * Surmodics Inc's reported EPS for the quarter was a loss
of 6
cents​.
    * The company reported a quarterly loss of $786 thousand.
    * Surmodics Inc shares had fallen by 3.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 25.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is  "buy."

Wall Street's median 12-month price target for Surmodics Inc is
$44.00 
This summary was machine generated from LSEG data February 1 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.30          0.00           Beat
 Sep. 30 2023      0.19           0.53           Beat
 Jun. 30 2023      0.05           0.52           Beat
 Mar. 31 2023      -0.51          -0.40          Beat